Principal Financial Group »

4d Molecular Therapeutics In shares owned by Principal Financial Group

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Principal Financial Group from 13F filings

Historical chart of Principal Financial Group investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Principal Financial Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $611k 19k 31.86
2023-12-31 $202k 10k 20.26
2023-09-30 $141k 11k 12.73